Literature DB >> 7956405

Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania.

C Richter1, R Perenboom, I Mtoni, J Kitinya, H Chande, A B Swai, R R Kazema, L M Chuwa.   

Abstract

In a prospective study, we investigated whether human immunodeficiency virus (HIV) infection alters the clinical presentation in patients with tuberculous pleuritis. One hundred twelve of 118 patients who presented with pleural effusion suffered from tuberculosis (TB); 65 patients (58%) were HIV seropositive. Evidence of disseminated TB was found more often in HIV-positive than in HIV-negative patients (30.8% vs 10.6%, p < 0.02). Dyspnea, fever, night sweat, fatigue, and diarrhea, severe tachypnea, hepatomegaly, splenomegaly, and lymphadenopathy were significantly more common in HIV-infected than in HIV-negative patients with TB. The same applied to a negative Mantoux reaction, lower hemoglobin, higher beta 2-microglobulin values, and in pleural fluid, lower albumin and higher gamma-globulin levels. Among HIV-infected patients, PPD skin test anergy was significantly associated with relative low albumin and gamma-globulin levels of pleural fluid. However, the radiographic features did not differ with respect to HIV status; they were predominantly those of primary pleuritis (78% in each group). We conclude that coexisting HIV infection affects clinical and laboratory features, but not the radiographic presentation of patients with TB pleuritis in Tanzania.

Entities:  

Mesh:

Year:  1994        PMID: 7956405     DOI: 10.1378/chest.106.5.1471

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.

Authors:  Zahra Toossi; Mianda Wu; Christina S Hirsch; Harriet Mayanja-Kizza; Joy Baseke; Htin Aung; David H Canaday; Koh Fujinaga
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

2.  Pleural effusion in patients infected with the human immunodeficiency virus.

Authors:  O Trejo; J A Girón; E Pérez-Guzmán; E Segura; C Fernández-Gutiérrez; A García-Tapia; A J Clavo; A Bascuñana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

3.  Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.

Authors:  Z Toossi; C S Hirsch; M Wu; H Mayanja-Kizza; J Baseke; B Thiel
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

4.  Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.

Authors:  Z Toossi; H Mayanja-Kizza; J Baseke; P Peters; M Wu; A Abraha; H Aung; A Okwera; C Hirsch; E Arts
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 5.  A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients.

Authors:  A Aljohaney; K Amjadi; G G Alvarez
Journal:  Clin Dev Immunol       Date:  2012-03-14

6.  Global trends of research on tuberculous pleurisy over the past 15 years: A bibliometric analysis.

Authors:  Yiding Bian; Mingming Deng; Qin Zhang; Gang Hou
Journal:  Front Cell Infect Microbiol       Date:  2022-08-30       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.